Cargando…
Hepatitis C Virus Driven AXL Expression Suppresses the Hepatic Type I Interferon Response
Treatment of chronic hepatitis C virus (HCV) infection is evolving rapidly with the development of novel direct acting antivirals (DAAs), however viral clearance remains intimately linked to the hepatic innate immune system. Patients demonstrating a high baseline activation of interferon stimulated...
Autores principales: | Read, Scott A., Tay, Enoch S., Shahidi, Mahsa, O’Connor, Kate S., Booth, David R., George, Jacob, Douglas, Mark W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4551482/ https://www.ncbi.nlm.nih.gov/pubmed/26313459 http://dx.doi.org/10.1371/journal.pone.0136227 |
Ejemplares similares
-
Hepatitis C Virus Induces the Cannabinoid Receptor 1
por: van der Poorten, David, et al.
Publicado: (2010) -
Macrophage Coordination of the Interferon Lambda Immune Response
por: Read, Scott A., et al.
Publicado: (2019) -
PEMT Mediates Hepatitis C Virus-Induced Steatosis, Explains Genotype-Specific Phenotypes and Supports Virus Replication
por: Abomughaid, Mosleh, et al.
Publicado: (2023) -
Twist mediates suppression of inflammation by type I IFNs and Axl
por: Sharif, M. Nusrat, et al.
Publicado: (2006) -
Differential regulation of hepatic physiology and injury by the TAM receptors Axl and Mer
por: Zagórska, Anna, et al.
Publicado: (2020)